AI-assisted, human-published
02/05/2025 /Funding Events
Entos Pharmaceuticals Receives $4M Grant for Genetic Medicine Development
Entos Pharmaceuticals secures funding from CIRM to advance genetic medicine ENTLEP001 for treating congenital generalized lipodystrophy, demonstrating promising disease-modifying activity.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com